386 related articles for article (PubMed ID: 12477072)
1. Tests for inter-subject and total variabilities under crossover designs.
Lee Y; Shao J; Chow SC; Wang H
J Biopharm Stat; 2002 Nov; 12(4):503-34. PubMed ID: 12477072
[TBL] [Abstract][Full Text] [Related]
2. Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm.
Dubois A; Lavielle M; Gsteiger S; Pigeolet E; Mentré F
Stat Med; 2011 Sep; 30(21):2582-600. PubMed ID: 21793036
[TBL] [Abstract][Full Text] [Related]
3. Tests for the analysis of variance of crossover designs with correlated errors.
Bellavance F; Tardif S; Stephens MA
Biometrics; 1996 Jun; 52(2):607-12. PubMed ID: 8672705
[TBL] [Abstract][Full Text] [Related]
4. Power comparison of robust approximate and non-parametric tests for the analysis of cross-over trials.
Correa JA; Bellavance F
Stat Med; 2001 Apr; 20(8):1185-96. PubMed ID: 11304735
[TBL] [Abstract][Full Text] [Related]
5. On sample size determination in multi-armed confirmatory adaptive designs.
Wassmer G
J Biopharm Stat; 2011 Jul; 21(4):802-17. PubMed ID: 21516570
[TBL] [Abstract][Full Text] [Related]
6. Power analyses for correlations from clustered study designs.
Tu XM; Kowalski J; Crits-Christoph P; Gallop R
Stat Med; 2006 Aug; 25(15):2587-606. PubMed ID: 16025545
[TBL] [Abstract][Full Text] [Related]
7. Sample size determination for testing equality in a cluster randomized trial with noncompliance.
Lui KJ; Chang KC
J Biopharm Stat; 2011 Jan; 21(1):1-17. PubMed ID: 21191850
[TBL] [Abstract][Full Text] [Related]
8. Sample size determination based on rank tests in clinical trials.
Wang H; Chen B; Chow SC
J Biopharm Stat; 2003 Nov; 13(4):735-51. PubMed ID: 14584719
[TBL] [Abstract][Full Text] [Related]
9. Sample size calculation for the Power Model for dose proportionality studies.
Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
[TBL] [Abstract][Full Text] [Related]
10. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
Lui KJ; Chang KC
Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
[TBL] [Abstract][Full Text] [Related]
11. A comparison of recent methods for the analysis of small-sample cross-over studies.
Chen X; Wei L
Stat Med; 2003 Sep; 22(18):2821-33. PubMed ID: 12953282
[TBL] [Abstract][Full Text] [Related]
12. Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models.
Nguyen TT; Bazzoli C; Mentré F
Stat Med; 2012 May; 31(11-12):1043-58. PubMed ID: 21965170
[TBL] [Abstract][Full Text] [Related]
13. Tests for equivalence based on odds ratio for matched-pair design.
Liu JP; Fan HY; Ma MC
J Biopharm Stat; 2005; 15(6):889-901. PubMed ID: 16279349
[TBL] [Abstract][Full Text] [Related]
14. On sample size calculation based on odds ratio in clinical trials.
Wang H; Chow SC; Li G
J Biopharm Stat; 2002 Nov; 12(4):471-83. PubMed ID: 12477070
[TBL] [Abstract][Full Text] [Related]
15. The use of the triangular test with response-adaptive treatment allocation.
Coad DS; Ivanova A
Stat Med; 2005 May; 24(10):1483-93. PubMed ID: 15706635
[TBL] [Abstract][Full Text] [Related]
16. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
Lui KJ; Chang KC
Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
[TBL] [Abstract][Full Text] [Related]
17. Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observations.
Ogungbenro K; Aarons L
J Biopharm Stat; 2008; 18(6):1212-27. PubMed ID: 18991118
[TBL] [Abstract][Full Text] [Related]
18. A general approach for sample size and statistical power calculations assessing of interventions using a mixture model in the presence of detection limits.
Nie L; Chu H; Cole SR
Contemp Clin Trials; 2006 Oct; 27(5):483-91. PubMed ID: 16769254
[TBL] [Abstract][Full Text] [Related]
19. Sample size determination for testing equality in Poisson frequency data under an AB/BA crossover trial.
Lui KJ
Pharm Stat; 2013; 12(2):74-81. PubMed ID: 23364859
[TBL] [Abstract][Full Text] [Related]
20. Sample size determination for alternate periods of use study designs with binary responses.
Morel JG; Neerchal NK
J Biopharm Stat; 2012; 22(2):351-67. PubMed ID: 22251179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
